Cholesterol Drug Prevents Heart Attacks — But It Doesn’t Come Cheap – NewsOK.com

WASHINGTON — For the first time, research shows that a pricey new medication called Repatha not only dramatically lowers LDL cholesterol, the “bad cholesterol,” it also reduces patients’ risk of dying or being hospitalized.

Repatha, a man-made antibody also known as evolocumab, cut the combined risk of heart attack, stroke and cardiovascular-related death in patients with heart disease by 20 percent, a finding that could lead more people to take the drug, according to a studypresented Friday at a meeting of the American College of Cardiology.

Some doctors hailed the results as major progress against heart disease. In an editorial in The New England Journal of Medicine, Dr. Robin Dullaart, a researcher at the University of Groningen in the Netherlands, called it a landmark study.

Read more from Kaiser Health News.

You might also be interested in…

Cholesterol Drug Prevents Heart Attacks — But It Doesn’t Come Cheap – NewsOK.com

Leave a Reply


Clickbank Products

Featured Links

    Search Archive

    Search by Date
    Search by Category
    Search with Google

    Photo Gallery


    Clickbank Products
    Log in | Designed by Gabfire themes